A Cutting-Edge Technology Provides Preimplantation Genetic Testing for IVF Parents
July 8, 2019
A cutting-edge technology that offers IVF parents and families a cost-effective means to evaluate genetic risks
Meet Genomic Prediction, which provides advanced genetic testing for IVF. They have developed a novel, genome-wide molecular genotyping methodology for preimplantation genetic testing of embryos.
Dr. Nathan Treff, Chief Scientific Officer at Genomic Prediction, joins us to discuss the cutting-edge technology that offers IVF parents and families a cost-effective means to evaluate genetic risks due to chromosomal abnormalities, single-gene disorders, and multi-gene disorders, known as polygenic diseases such as diabetes, cancer, and heart disease.
Their approach provides an unparalleled level of options for identifying potential disease risk in embryos and improving newborn health outcomes.
For Genomic Prediction, it’s about helping IVF parents be more knowledgeable, showing them the risks and providing options to help make the best and most informed decisions for their families.
Behind the Mystery is a special segment dedicated to revolutionizing the way the health care system works for those suffering from a rare and genetic disorder.
Behind the Mystery takes a closer look at one of the two types of Polycystic Kidney disease. Autosomal Dominant Polycystic Kidney Disease, or ADPKD, is a rare, genetic condition.
Behind the Mystery takes a closer look at Blastic Plasmacytoid Dendritic Cell Neoplasm, a rare disease that is often misdiagnosed and affects at least 500 to 1,000 patients each year in the U.S.